N-[5-(1H-benzimidazol-2-yl)-1-methylpyrazol-3-yl]-2-methyl-6-[4-(oxetan-3-yl)piperazin-1-yl]pyridine-3-carboxamide
C25H28N8O2 — CID 163227961
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-(1H-benzimidazol-2-yl)-1-methylpyrazol-3-yl]-2-methyl-6-[4-(oxetan-3-yl)piperazin-1-yl]pyridine-3-carboxamide
N-[5-(1H-benzimidazol-2-yl)-1-methylpyrazol-3-yl]-2-methyl-6-[4-(oxetan-3-yl)piperazin-1-yl]pyridine-3-carboxamide (PubChem CID 163227961) has the molecular formula C25H28N8O2 and a molecular weight of 472.55 g/mol. Its IUPAC name is N-[5-(1H-benzimidazol-2-yl)-1-methylpyrazol-3-yl]-2-methyl-6-[4-(oxetan-3-yl)piperazin-1-yl]pyridine-3-carboxamide.
Molecular Properties
| Compound Name | N-[5-(1H-benzimidazol-2-yl)-1-methylpyrazol-3-yl]-2-methyl-6-[4-(oxetan-3-yl)piperazin-1-yl]pyridine-3-carboxamide |
|---|---|
| PubChem CID | 163227961 |
| Molecular Formula | C25H28N8O2 |
| Molecular Weight | 472.55 g/mol |
| Exact Mass | 472.23 |
| IUPAC Name | N-[5-(1H-benzimidazol-2-yl)-1-methylpyrazol-3-yl]-2-methyl-6-[4-(oxetan-3-yl)piperazin-1-yl]pyridine-3-carboxamide |
| SMILES | Cc1nc(N2CCN(C3COC3)CC2)ccc1C(=O)Nc1cc(-c2nc3ccccc3[nH]2)n(C)n1 |
| InChI | InChI=1S/C25H28N8O2/c1-16-18(7-8-23(26-16)33-11-9-32(10-12-33)17-14-35-15-17)25(34)29-22-13-21(31(2)30-22)24-27-19-5-3-4-6-20(19)28-24/h3-8,13,17H,9-12,14-15H2,1-2H3,(H,27,28)(H,29,30,34) |
| InChIKey | WFLDJRGKSZSLGN-UHFFFAOYSA-N |
| XLogP | 2.44 |
| TPSA | 104.20 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 472.55 |
| LogP ≤ 5 | 2.44 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163227961 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.